Johnson & Johnson (JNJ) Acquisitions (2009 - 2026)

Johnson & Johnson has disclosed Acquisitions across 18 years of filings, most recently posting -$17.2 billion for Q2 2026.

• In Q2 2026, Acquisitions fell 219.22% year-over-year to -$17.2 billion; the TTM figure through Jun 2026 stood at $3.3 billion (down 79.67% YoY), while the FY2025 annual figure was $17.5 billion, up 15.54% from the prior year.
• Acquisitions came in at -$17.2 billion for Q2 2026 at Johnson & Johnson, down from $17.5 billion in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $17.7 billion in Q1 2023 to a low of -$17.2 billion in Q2 2026.
• Average Acquisitions over 5 years is $3.6 billion, with a median of $1.8 billion recorded in 2024.
• Year-over-year, Acquisitions surged 304000.0% in 2025 and slumped 219.22% in 2026.
• Over 5 years, Acquisitions stood at $252.0 million in 2022, then surged by 653.97% to $1.9 billion in 2023, then tumbled by 99.95% to $1.0 million in 2024, then surged by 304000.0% to $3.0 billion in 2025, then sank by 666.82% to -$17.2 billion in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were -$17.2 billion in Q2 2026, $17.5 billion in Q1 2026, and $3.0 billion in Q4 2025.